ESSA Pharma Inc. (EPIX) Financials

EPIX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 144.5 million 3.8 million
2023-09-30 149.1 million 3.5 million
2023-06-30 153.7 million 3.4 million
2023-03-31 158.5 million 2.2 million

EPIX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.8 million 803418
2023-09-30 -4.5 million 845697
2023-06-30 -3.3 million 1.2 million
2023-03-31 -7.0 million 1.4 million

EPIX Net Income

No data available :(

EPIX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 142.1 million - 374835
2023-09-30 148.1 million - 80328
2023-06-30 152.5 million - 111273
2023-03-31 44.3 million - 145268

EPIX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 44.1 million
2023-09-30 44.1 million
2023-06-30 44.1 million
2023-03-31 44.1 million

EPIX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 5.4 million 2.4 million -
2023-09-30 - 5.2 million 2.1 million -
2023-06-30 - 6.3 million 2.8 million -
2023-03-31 - 4.5 million 3.7 million -

EPIX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 29708
2023-09-30 - 27149
2023-06-30 - 30447
2023-03-31 - 30447

EPIX

Price: $6.88

52 week price:
2.56
11.67

Earnings Per Share: -0.59 USD

P/E Ratio: -16.33

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 44601

Ebitda: -1.8 million

Market Capitalization: 319.8 million

Links: